Overexpression of innate immune response genes in a model of recessive polycystic kidney disease

Kidney International

Volumn 73, Issue 1, 2008, Pages 63-76

  Mrug, M ^a   Zhou, J ^a   Woo, Y ^b   Cui, X ^a,c   Szalai, A J ^a,c   Novak, J ^c   Churchill, G A ^b   Guay Woodford, L M ^a,d,e  

^a University of Alabama at Birmingham   (United States)

^b JACKSON LABORATORY   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e University of Alabama at Birmingham   (United States)

Author keywords

Complement; cpk mouse; Innate immune response; Microarray; Recessive PKD

Indexed keywords

COMPLEMENT COMPONENT C3; MACROPHAGE ACTIVATING FACTOR; TRANSCRIPTOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; GENE EXPRESSION; GENE OVEREXPRESSION; INNATE IMMUNITY; KIDNEY EPITHELIUM; KIDNEY POLYCYSTIC DISEASE; MACROPHAGE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

EID: 37249025309     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5002627     Document Type: Article

References (50)

1. Gabow P. Autosomal dominant polycystic kidney disease. N Eng J Med 1993; 329: 332-342.
2. The European Polycystic Kidney Disease Consortium. The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. Cell 1994; 77: 881-894.
3. The American PKD1 Consortium. Analysis of the genomic sequence for the autosomal dominant polycystic kidney disease (PKD1) gene predicts the presence of a leucine-rich repeat. Hum Mol Genet 1995; 4: 575-582.
4. The International Polycystic Kidney Disease Consortium. Polycystic kidney disease: the complete structure of the PKD1 gene and its protein. Cell 1995; 8: 289-298.
5. Mochizuki T, Wu G, Hayashi T et al. PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 1996; 272: 1339-1342.
6. Onuchic L, Furu L, Nagasawa Y et al. PKHD1, the polycystic kidney and hepatic disease 1 gene, encodes a novel large protein containing multiple IPT domains and PbH1 repeats. Am J Hum Genet 2002; 70: 1305-1317.
7. Ward C, Hogan M, Rossetti S et al. The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein. Nat Genet 2002; 30: 259-269.
8. Yoder BK, Hou X, Guay-Woodford LM. The polycystic kidney disease proteins, polycystin-1, polycystin-2, polaris, and cystin, are co-localized in renal cilia. J Am Soc Nephrol 2002; 13: 2508-2516.
9. Lin F, Hiesberger T, Cordes K et al. Kidney-specific inactivation of the KIF3A subunit of kinesin-II inhibits renal ciliogenesis and produces polycystic kidney disease. Proc Natl Acad Sci USA 2003; 100: 5286-5291.
10. Morgan D, Eley L, Sayer J et al. Expression analyses and interaction with the anaphase promoting complex protein Apc2 suggest a role for inversin in primary cilia and involvement in the cell cycle. Hum Mol Gen 2002; 11: 3345-3350.
11. Taulman P, Haycraft C, Balkovetz D, Yoder B. Polaris, a protein involved in left-right axis patterning, localizes to basal bodies and cilia. Mol Biol Cell 2001; 12: 589-599.
12. Brown N, Murcia N. Delayed cystogenesis and increased ciliogenesis associated with the re-expression of polaris in Tg737 mutant mice. Kidney Int 2003; 63: 1220-1229.
13. Hou X, Mrug M, Yoder B et al. Cystin, a novel cilia-associated protein, is disrupted in the cpk mouse model of polycystic kidney disease. J Clin Invest 2002; 109: 533-540.
14. Woo D, Miao S, Pelayo J, Woolf A. Taxol inhibits progression of congenital polycystic kidney disease. Nature 1994; 368: 750-753.
15. Praetorius H, Spring K. Bending the MDCK cell primary cilium increases intracellular calcium. J Membr Biol 2001; 184: 71-79.
16. Praetorius H, Spring K. Removal of the MDCK cell primary cilium abolished flow sensing. J Membr Biol 2003; 10: 1-9.
17. Koulen P, Cai Y, Geng L et al. Polycystin-2 is an intracellular calcium release channel. Nat Cell Biol 2002; 4: 191-197.
18. Yoder BK, Mulroy S, Eustace H et al. Molecular pathogenesis of autosomal dominant polycystic kidney disease. Expert Rev Mol Med 2006; 8: 1-22.
19. Kim K, Drummond I, Ibraghimov-Beskrovnaya O et al. Polycystin 1 is required for the structural integrity of blood vessels. Proc Natl Acad Sci USA 2000; 97: 1731-1736.
20. Lee JE, Park MH, Park JH. The gene expression profile of cyst epithelial cells in autosomal dominant polycystic kidney disease patients. J Biochem Mol Biol 2004; 37: 612-617.
21. Husson H, Manavalan P, Akmaev VR et al. New insights into ADPKD molecular pathways using combination of SAGE and microarray technologies. Genomics 2004; 84: 497-510.
22. Schieren G, Rumberger B, Klein M et al. Gene profiling of polycystic kidneys. Nephrol Dial Transplant 2006; 21: 1816-1824.
23. Riera M, Burtey S, Fontes M. Transcriptome analysis of a rat PKD model: importance of genes involved in extracellular matrix metabolism. Kidney Int 2006; 69: 1558-1563.
24. Preminger G, Koch W, Fried F et al. Murine congenital polycystic kidney disease: a model for studying development of cystic disease. J Urol 1982; 127: 556-560.
25. Fry J, Koch W, Jennette J et al. A genetically determined murine model of infantile polycystic kidney disease. J Urol 1985; 134: 828-833.
26. Avner E, Studnicki F, Young M et al. Congenital murine polycystic kidney disease. I. The ontogeny of tubular cyst formation. Pediatr Nephrol 1987; 2: 210-218.
27. Cogswell C, Price S, Hou X et al. Positional cloning of jcpk/bpk locus of the mouse. Mamm Genome 2003; 14: 242-249.
28. Nauta J, Ozawa Y, Sweeney W et al. Renal and biliary abnormalities in a new murine model of autosomal recessive polycystic kidney disease. Pediatr Nephrol 1993; 7: 163-172.
29. Richards W, Sweeney W, BK BY et al. Epidermal growth factor receptor activity mediates renal cyst formation in polycystic kidney disease. J Clin Invest 1998; 101: 935-939.
30. Moyer J, Lee-Tischler M, Kwon H-Y et al. Candidate gene associated with a mutation causing recessive polycystic kidney disease in mice. Science 1994; 264: 1329-1333.
31. Mrug M, Li R, Cui X et al. Kinesin family member 12 is a candidate polycystic kidney disease modifier in the cpk mouse. J Am Soc Nephrol 2005; 16: 905-916.
32. Zhang W, Morris QD, Chang R et al. The functional landscape of mouse gene expression. J Biol 2004; 3: 21.
33. Madsen K, Tisher C. Anatomy of the kidney. In: Brenner B (ed). Brenner and Rector's the Kidney, 7th edn, vol. 1. Elsevier Inc.: Philadelphia, 2004, pp. 4-72.
34. Chabardes-Garonne D, Mejean A, Aude JC et al. A panoramic view of gene expression in the human kidney. Proc Natl Acad Sci USA 2003; 100: 13710-13715.
35. Ricker J, Gattone V, Calvet J, Rankin C. Development of autosomal recessive polycystic kidney disease in BALB/c-cpk/cpk mice. J Am Soc Nephrol 2000; 11: 1837-1847.
36. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003; 3: 23-35.
37. Mevorach D, Mascarenhas JO, Gershov D, Elkon KB. Complement-dependent clearance of apoptotic cells by human macrophages. J Exp Med 1998; 188: 2313-2320.
38. Cowley Jr BD, Ricardo SD, Nagao S, Diamond JR. Increased renal expression of monocyte chemoattractant protein-1 and osteopontin in ADPKD in rats. Kidney Int 2001; 60: 2087-2096.
39. Torres VE, Harris PC. Mechanisms of disease: autosomal dominant and recessive polycystic kidney diseases. Nat Clin Pract Nephrol 2006; 2: 40-55; quiz 55.
40. Schraufstatter IU, Trieu K, Sikora L et al. Complement c3a and c5a induce different signal transduction cascades in endothelial cells. J Immunol 2002; 169: 2102-2110.
41. Needham LK, Rozengurt E. Galpha12 and Galpha13 stimulate Rho-dependent tyrosine phosphorylation of focal adhesion kinase, paxillin, and p130 Crk-associated substrate. J Biol Chem 1998; 273: 14626-14632.
42. Wilson P. Polycystic kidney disease. N Engl J Med 2004; 350: 151-164.
43. Bohuslav J, Horejsi V, Hansmann C et al. Urokinase plasminogen activator receptor, beta 2-integrins, and Src-kinases within a single receptor complex of human monocytes. J Exp Med 1995; 181: 1381-1390.
44. Zahedi R, Braun M, Wetsel RA et al. The C5a receptor is expressed by human renal proximal tubular epithelial cells. Clin Exp Immunol 2000; 121: 226-233.
45. Peake PW, O'Grady S, Pussell BA, Charlesworth JA. C3a is made by proximal tubular HK-2 cells and activates them via the C3a receptor. Kidney Int 1999; 56: 1729-1736.
46. Irizarry R, Bolstad B, Collin F et al. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 2003; 31: e15.
47. Cui X, Hwang JT, Qiu J et al. Improved statistical tests for differential gene expression by shrinking variance components estimates. Biostatistics 2005; 6: 59-75.
48. Storey J. A direct approach to false discovery rates. J R Stat Soc Ser B 2002; 64: 479-498.
49. Storey J, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci USA 2003; 100: 9440-9445.
50. Vandesompele J, Preter KD, Pattyn F et al. Accurate normalization of realtime quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002; 3: 0034.I-0034.II.